SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling

CompletedOBSERVATIONAL
Enrollment

779

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
SARS-CoV 2
Interventions
BIOLOGICAL

Saliva collection

Saliva samples are regularly collected over a period of up to 30 consecutive days.

OTHER

Clinical assessment

The participant's clinical data will be collected regularly over a period of up to 30 consecutive days.

Trial Locations (1)

13013

Hôpital d'Instruction des Armées Laveran, Marseille

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER